PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Vistagen Therapeutics, Inc.
Filed: December 31, 2020
Period of Report: December 31, 2020
Accession Number: 0001654954-20-014095

View Document ↗ View on SEC.gov ↗